Apnea

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2024-09-18
EMA Authorised: Peyona (previously Nymusa) (Caffeine citrate) — Chiesi Farmaceutici SpA
EMA authorised Peyona (formerly Nymusa), a caffeine citrate medicine, for the treatment of apnea, with Chiesi Farmaceutici SpA as the market…